Search results
Results From The WOW.Com Content Network
Updated COVID-19 shots are becoming increasingly available in Texas after weeks of hiccups and distribution glitches since the vaccine was approved for people 6 months and older last month ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville, California. It is licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...
Gov. Greg Abbott issued an executive order on Wednesday banning any state or local mandates requiring people to be vaccinated against COVID-19, and he called on Texas legislators to vote it into ...
A Texas district is staying open through an intense COVID-19 outbreak across its schools, and a number of colleges updated their vaccination policies to mandate the shot following Pfizer's full ...
The death rate in Texas was 175 for every 100,000 people, while national COVID-19 death rate was 179 per 100,000. [6] As of April 3, 2021, vaccination in Texas lagged behind the US average, with rates lower than in three of four neighboring states, having administered 12,565,129 COVID-19 vaccine doses, equivalent to 43,334 doses per-100,000 of ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...